Table of Contents
ISRN Obstetrics and Gynecology
Volume 2014 (2014), Article ID 536495, 5 pages
http://dx.doi.org/10.1155/2014/536495
Research Article

Evaluation of the Oncogenic Human Papillomavirus DNA Test with Liquid-Based Cytology in Primary Cervical Cancer Screening and the Importance of the ASC/SIL Ratio: A Belgian Study

1Faculty of Medicine, Free University of Brussels, Brussels, Belgium
2Department of Pathology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, 6041 Gosselies, Belgium
3Unit of Gynecology, Erasme University Hospital-ULB, Brussels, Belgium
4Unit of Gynecopathology, Department of Pathology, Erasme University Hospital-ULB, Brussels, Belgium

Received 9 November 2013; Accepted 30 December 2013; Published 18 February 2014

Academic Editors: K. Chan, C. Iavazzo, Y.-S. Song, and L. C. Zeferino

Copyright © 2014 Xavier Catteau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Monsonego, M. G. Hudgens, L. Zerat et al., “Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study,” International Journal of Cancer, vol. 129, no. 3, pp. 691–701, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Cancer Survival in Belgium, Belgian Cancer Registry, Brussels, Belgium, 2012.
  3. V. Cogliano, R. Baan, K. Straif, Y. Grosse, B. Secretan, and F. El Ghissassi, “Carcinogenicity of human papillomaviruses,” The Lancet Oncology, vol. 6, no. 4, p. 204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. H. zur Hausen, M. Arbyn, L. Villa, and IARC Monograph Working Group, IARC Monographs on the Evaluation of Carcinogenic Risks To Humans, vol. 90 of Human Papillomaviruses, IARC Press, Lyon, France, 2007.
  5. E. Franco, K. Syrjanen, C. de Wolf et al., “New developments in cervical cancer screening and prevention.Geneva, Switzerland, June 17-19 1996,” Cancer Epidemiology Biomarkers and Prevention, vol. 5, no. 10, pp. 853–856, 1996. View at Google Scholar · View at Scopus
  6. A. B. Miller, S. Nazeer, S. Fonn et al., “Report on consensus conference on cervical cancer screening and management,” International Journal of Cancer, vol. 86, no. 2, pp. 440–447, 2000. View at Google Scholar · View at Scopus
  7. D. Solomon, D. Davey, R. Kurman et al., “The 2001 Bethesda system: terminology for reporting results of cervical cytology,” The Journal of the American Medical Association, vol. 287, no. 16, pp. 2114–2119, 2002. View at Google Scholar · View at Scopus
  8. J.-C. Boulanger and H. Sevestre, “ASCUS: an update,” Gynecologie Obstetrique Fertilite, vol. 34, no. 1, pp. 44–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Juan, “Liquid-based. Thin-layer cytology,” in Colposcopy: Principles and Practice, B. Apgar, M. Brotzman, and M. Spitzer, Eds., Saunders, Philadelphia, Pa, USA, 2002. View at Google Scholar
  10. WHO, IARC Handbooks of Cancer Prevention—Cervix Cancer Screening, vol. 10, IARC Press, Lyon, France, 2005.
  11. C. Bergeron, F. Cas, F. Fagnani, A. Contrepas, R. Wadier, and J.-D. Poveda, “Assessment of human papillomavirus testing on liquid-based cyto-screen system for women with atypical squamous cells of undetermined significance. Effect of age,” Gynecologie Obstetrique Fertilite, vol. 34, no. 4, pp. 312–316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Arbyn, F. Buntinx, M. van Ranst, E. Paraskevaidis, P. Martin-Hirsch, and J. Dillner, “Virologic versus cytologic triage of women with equivocal pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia,” Journal of the National Cancer Institute, vol. 96, no. 4, pp. 280–293, 2004. View at Google Scholar · View at Scopus
  13. M. Arbyn, P. Sasieni, C. J. L. M. Meijer, C. Clavel, G. Koliopoulos, and J. Dillner, “Chapter 9: clinical applications of HPV testing: a summary of meta-analyses,” Vaccine, vol. 24, no. 3, pp. S78–S89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. Sherman, M. Schiffman, and J. T. Cox, “Effects of age and human papilloma viral load on colposcopy triage: data from the randomized atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS),” Journal of the National Cancer Institute, vol. 94, no. 2, pp. 102–107, 2002. View at Google Scholar · View at Scopus
  15. M. Arbyn, E. Paraskevaidis, P. Martin-Hirsch, W. Prendiville, and J. Dillner, “Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence,” Gynecologic Oncology, vol. 99, no. 3, pp. S7–S11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. D. Duncan and S. V. Jacob, “Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this New Bethesda system diagnostic category,” Diagnostic Cytopathology, vol. 32, no. 4, pp. 243–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Chivukula and V. B. Shidham, “ASC-H in Pap test- definitive categorization of cytomorphological spectrum,” CytoJournal, vol. 3, article 14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. M. Clifford, R. K. Rana, S. Franceschi, J. S. Smith, G. Gough, and J. M. Pimenta, “Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 5, pp. 1157–1164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Smith, L. Lindsay, B. Hoots et al., “Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update,” International Journal of Cancer, vol. 121, no. 3, pp. 621–632, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Clifford, S. Franceschi, M. Diaz, N. Muñoz, and L. L. Villa, “Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases,” Vaccine, vol. 24, supplement 3, pp. S26–S34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. zur Hausen, “Papillomaviruses in the causation of human cancers—a brief historical account,” Virology, vol. 384, no. 2, pp. 260–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. C. Kitchener, M. Almonte, C. Thomson et al., “HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial,” The Lancet Oncology, vol. 10, no. 7, pp. 672–682, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. G. Baseman, S. L. Kulasingam, T. G. Harris et al., “Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States,” American Journal of Obstetrics and Gynecology, vol. 199, no. 1, pp. 26.e1–26.e8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Dalstein, D. Riethmuller, J. L. Sautière et al., “Detection of cervical precancer and cancer in a hospital population: benefits of testing for human papillomavirus,” European Journal of Cancer, vol. 40, no. 8, pp. 1225–1232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. D. C. Chhieng, J. Chen, K. Connolly, J. Roberson, and I. Eltoum, “High-risk HPV DNA detection rate in patients with atypical squamous cells and its relationship to the atypical squamous cell:squamous intraepithelial lesion ratio,” Acta Cytologica, vol. 50, no. 3, pp. 291–294, 2006. View at Google Scholar · View at Scopus
  26. R. Juskevicius, K. H. Zou, and E. S. Cibas, “An analysis of factors that influence the ASCUS/SIL ratio of pathologists,” American Journal of Clinical Pathology, vol. 116, no. 3, pp. 331–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. A. F. Nascimento and E. S. Cibas, “The ASC/SIL ratio for cytopathologists as a quality control measure: a follow-up study,” American Journal of Clinical Pathology, vol. 128, no. 4, pp. 653–656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. D. D. Davey, S. Woodhouse, P. Styer, J. Stastny, and D. Mody, “Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology,” Archives of Pathology and Laboratory Medicine, vol. 124, no. 2, pp. 203–211, 2000. View at Google Scholar · View at Scopus
  29. A. A. Renshaw, M. Auger, G. Birdsong et al., “ASC/SIL ratio for cytotechnologists: a survey of its utility in clinical practice,” Diagnostic Cytopathology, vol. 38, no. 3, pp. 180–183, 2010. View at Publisher · View at Google Scholar · View at Scopus